Biogen Inc (BIIB)
224.93
+4.86
(+2.21%)
USD |
NASDAQ |
May 31, 16:00
224.94
+0.01
(+0.00%)
After-Hours: 20:00
Biogen Cash and Short Term Investments (Annual): 1.050B for Dec. 31, 2023
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.050B |
| December 31, 2022 | 4.893B |
| December 31, 2021 | 3.802B |
| December 31, 2020 | 2.610B |
| December 31, 2019 | 4.476B |
| December 31, 2018 | 3.538B |
| December 31, 2017 | 3.689B |
| December 31, 2016 | 4.895B |
| December 31, 2015 | 3.428B |
| December 31, 2014 | 1.845B |
| December 31, 2013 | 1.223B |
| December 31, 2012 | 1.706B |
| December 31, 2011 | 1.691B |
| December 31, 2010 | 1.208B |
| December 31, 2009 | 1.264B |
| December 31, 2008 | 1.342B |
| December 31, 2007 | 1.184B |
| December 31, 2006 | 902.69M |
| December 31, 2005 | 850.75M |
| December 31, 2004 | 209.45M |
| Date | Value |
|---|---|
| December 31, 2003 | 314.85M |
| December 31, 2002 | 787.77M |
| December 31, 2001 | 798.11M |
| December 31, 2000 | 682.41M |
| December 31, 1999 | 654.54M |
| December 31, 1998 | 516.91M |
| December 31, 1997 | 440.09M |
| December 31, 1996 | 321.38M |
| December 31, 1995 | 307.95M |
| December 31, 1994 | 267.80M |
| December 31, 1993 | 74.50M |
| December 31, 1992 | 85.90M |
| December 31, 1991 | 56.60M |
| December 31, 1990 | 12.60M |
| December 31, 1989 | 33.20M |
| December 31, 1988 | 54.30M |
| December 31, 1987 | 54.40M |
| December 31, 1986 | 70.50M |
| December 31, 1985 | 53.50M |
| December 31, 1984 | 74.90M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Annual) Range, Past 5 Years
1.050B
Minimum
2023
4.893B
Maximum
2022
3.366B
Average
3.802B
Median
2021
Cash and Short Term Investments (Annual) Benchmarks
| Ionis Pharmaceuticals Inc | 2.331B |
| Eli Lilly and Co | 2.928B |
| Bristol-Myers Squibb Co | 12.28B |
| Regeneron Pharmaceuticals Inc | 10.84B |
| Sage Therapeutics Inc | 753.18M |